Navigation Links
QMed, Inc. Retains Lazard Middle Market
Date:11/12/2007

EATONTOWN, N.J., Nov. 12 /PRNewswire-FirstCall/ -- QMed, Inc., (Nasdaq: QMED) today announced that it has retained Lazard Middle Market to assist it in exploring strategic alternatives. Lazard Middle Market is the middle market financial advisory business of Lazard. Barry Freeman and Ryan Stewart with Lazard Middle Market Healthcare Services group will manage the process and will report to QMed's Board of Directors.

Additionally, Bruce Wesson, QMed's Chairman, has resigned from the board. "We thank Bruce for all his years of service and dedication to the Company," said Jane Murray, QMed's President and Chief Executive Officer. QMed's Board of Directors continues to consist of Jane Murray and three outside directors.

About QMed, Inc.

QMed has developed evidence-based clinical information management systems for use by health plan customers. The QMed systems incorporate Disease Management services to patients and decision support to physicians. The Company's subsidiaries have specialized in serving high-risk populations of Medicare beneficiaries.

Except for historical information contained herein, matters discussed in this news release are forward-looking statements that involve risks and uncertainties. They include but are not limited to those relating to the timely implementation of programs, the impact of business and operational conditions, competitive product introductions, acceptance and pricing, and those risks detailed in the Company's filings with the Securities and Exchange Commission (SEC). Actual results may differ materially from any forward-looking statements due to these risks and uncertainties.

For more information contact:

QMed, Inc.:

Jane Murray (732) 544-5544

Lazard Middle Market:

Barry Freeman (312) 928-0760 x17

bfreeman@agio.com

Ryan Stewart (612) 803-2215

rstewart@agio.com


'/>"/>
SOURCE QMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
2. QMed, Inc. Extends Agreement & Receives $550,000 Performance Bonus
3. QMed, Inc. Reports Third Quarter Results
4. Assured Pharmacy Retains Empire Financial Group
5. Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations
6. Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations
7. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
8. Genesis Technology Group Retains CCG Elite
9. The Ultimate Stress Reliever, SpaCapsule(R), the Capsule that Takes You on a Rejuvenating Journey to the Spa, Retains TransMedia Group for Soothing PR
10. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
11. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The ... the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. ... safety. Only a few hospitals and facilities have earned this distinction. This is ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ ... announced the first national #QuackGivesBack campaign which supported local breast cancer organizations during ... franchise-wide Quack Gives Back initiative, and we’re very pleased with the ...
(Date:12/8/2016)... Pa. (PRWEB) , ... December 08, 2016 , ... ... Medicine Southern Chester County, a Property owned by an affiliate of Seavest, has ... square foot Penn Medicine Southern Chester County ambulatory care center (ACC) was named ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... CURE Media ... centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat ... the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to team ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research ... Electrodes Market Analysis and Trends - Adhesion Type, Application, Usability - ... ... The Global Cardiology Electrodes Market is poised to grow at a ... prominent trends that the market is witnessing include advancements in extracellular ...
(Date:12/8/2016)... 8, 2016   TriNetX , the health ... Hospital signed a membership agreement to join ... of new cures. The TriNetX network ... million patients globally, biopharmaceutical companies and contract research ... protocol design, site selection, patient recruitment, and collaborative ...
Breaking Medicine Technology: